GO:0043512 inhibin A complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043512 (inhibin A complex) is a cellular_component term describing a heterodimeric hormone made of an inhibin alpha subunit and an inhibin beta-A subunit.
• Inhibin A is a TGF-beta superfamily ligand that can be bound by the secreted protein follistatin, forming a stable complex that does not block activin A antagonism.
• Betaglycan (TGFBR3) acts as a coreceptor for inhibin A, but not inhibin B, in pituitary gonadotrope cells, providing a mechanistic basis for inhibin A-specific signaling.
• Inhibin A has been implicated in tumor angiogenesis and metastasis as a paracrine factor, expanding its relevance beyond reproductive endocrinology.
• Inhibin A and activin A modulate oocyte maturation in vitro, showing direct functional effects on germ cell development.
• Nanobodies targeting the inhibin alpha subunit have been generated, offering new tools for detection and functional studies of inhibin A.
Description
The inhibin A complex (GO:0043512) is a secreted heterodimeric hormone composed of an inhibin alpha subunit disulfide-linked to an inhibin beta-A subunit. It belongs to the transforming growth factor beta (TGF-beta) superfamily and functions as a key endocrine and paracrine regulator, most classically in the hypothalamic-pituitary-gonadal axis. Because it is a cellular_component term, GO:0043512 describes the assembled molecular entity rather than a process or a single gene product, making it essential for annotating the extracellular hormone itself and its interactions. Inhibin A is perhaps best known for its ability to suppress follicle-stimulating hormone (FSH) secretion from pituitary gonadotrope cells, a function that requires the coreceptor betaglycan (TGFBR3). Unlike inhibin B, inhibin A specifically engages betaglycan to antagonize activin signaling, and this selectivity has been mapped to distinct receptor-ligand interfaces. The complex also interacts with follistatin, which binds inhibin A with high affinity but does not prevent inhibin A from antagonizing activin A. Beyond reproduction, inhibin A has emerged as a paracrine factor in tumor angiogenesis and metastasis, and it influences oocyte maturation in vitro. These findings position GO:0043512 as a node connecting endocrine regulation, reproductive biology, and cancer biology. Researchers studying this complex need reliable tools to detect, quantify, and perturb its subunits, which is where CRISPR-based cell models and targeted assays become valuable.
inhibin A complex At A Glance
| GO ID | GO:0043512 |
|---|---|
| GO term | inhibin A complex |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Heterodimeric hormone that regulates endocrine and paracrine signaling, including FSH suppression and modulation of activin A responses |
| Complex composition | Inhibin alpha subunit + inhibin beta-A subunit |
| Key interacting protein | Follistatin forms a stable complex with inhibin A without interfering with activin A antagonism |
| Coreceptor | Betaglycan (TGFBR3) functions as an inhibin A coreceptor in pituitary gonadotrope cells |
| Related ligand | Activin A, a related TGF-beta superfamily ligand whose signaling is antagonized by inhibin A |
What Is GO:0043512?
The inhibin A complex is a heterodimeric hormone consisting of an inhibin alpha subunit covalently linked to an inhibin beta-A subunit. According to the QuickGO definition for GO:0043512, it is a heterodimeric hormone composed of an inhibin alpha subunit complexed with an inhibin beta-A subunit. This entity is a cellular_component because it represents a discrete secreted protein complex, not a catalytic activity or a biological process. The complex is a member of the TGF-beta superfamily and acts through receptors and coreceptors such as betaglycan to modulate signaling.
Why Is inhibin A complex Important in Cell Biology?
The inhibin A complex is important because it is a central endocrine signal that controls FSH secretion and reproductive function, and it is increasingly recognized as a paracrine regulator in cancer and germ cell biology. Its selective interaction with betaglycan distinguishes it from inhibin B and provides a molecular explanation for isoform-specific signaling. Understanding GO:0043512 therefore informs studies of fertility, pituitary physiology, tumor angiogenesis, and TGF-beta superfamily signaling, and it enables precise annotation of secreted hormone complexes in genomic and proteomic datasets.
• Regulates follicle-stimulating hormone (FSH) secretion from pituitary gonadotrope cells.
• Acts as a selective ligand for betaglycan (TGFBR3), unlike inhibin B.
• Forms a stable complex with follistatin, which modulates its bioavailability.
• Functions as a paracrine factor in tumor angiogenesis and metastasis.
• Modulates oocyte maturation in vitro together with activin A.
• Is part of the TGF-beta superfamily, connecting it to broad signaling networks.
• Provides a biomarker and functional readout in reproductive endocrinology.
• Can be targeted by nanobodies against the inhibin alpha subunit for detection and perturbation.
• Serves as a model for understanding heterodimeric hormone assembly and receptor selectivity.
Structure and Composition of inhibin A complex
Subunit composition and disulfide linkage
In simple terms: Inhibin A is made of two different protein chains that are joined together.
The inhibin A complex is a heterodimer composed of an inhibin alpha subunit and an inhibin beta-A subunit. The two subunits are covalently linked, forming a secreted hormone that belongs to the TGF-beta superfamily. This heterodimeric architecture is the defining feature of GO:0043512 and distinguishes it from homodimeric activins, which are formed by beta subunits.
Interaction with follistatin
In simple terms: A protein called follistatin can stick to inhibin A without stopping its function.
Follistatin forms a stable complex with inhibin A, and this interaction does not interfere with inhibin A antagonism of activin A. This is notable because follistatin is classically known as an activin-binding protein, and its ability to bind inhibin A expands its regulatory repertoire. The follistatin-inhibin A complex represents a distinct molecular entity from the free hormone, and its formation may influence the bioavailability and clearance of inhibin A.
Betaglycan as a coreceptor
In simple terms: A receptor called betaglycan helps inhibin A work specifically in pituitary cells.
Betaglycan (TGFBR3) functions as an inhibin A coreceptor in pituitary gonadotrope cells, but it does not serve the same role for inhibin B. This coreceptor selectivity provides a mechanistic explanation for why inhibin A and inhibin B have distinct biological activities despite sharing the alpha subunit. Structural studies of TGF-beta with betaglycan and signaling receptors have revealed general principles of complex assembly that are relevant to understanding how inhibin A engages its receptor system.
Assembly and secretion
In simple terms: The two subunits are produced inside the cell and then assembled and released as a hormone.
The inhibin alpha and beta-A subunits are translated as precursor proteins that undergo processing and assembly before secretion. The mature heterodimeric hormone is the functional entity annotated as GO:0043512. Because it is a secreted complex, its assembly and secretion are critical for its endocrine and paracrine actions.
Key Genes Involved in GO:0043512 inhibin A complex
The following genes and proteins are directly or functionally linked to the inhibin A complex and its signaling context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INHA | Encodes the inhibin alpha subunit, a core component of inhibin A | Essential for forming the heterodimer; target for knockout and mutation studies |
| INHBA | Encodes the inhibin beta-A subunit, the other core component of inhibin A | Required for inhibin A assembly; also forms activin A homodimers |
| FST | Encodes follistatin, which binds inhibin A and activin A | Modulates inhibin A bioavailability and complex formation |
| TGFBR3 | Encodes betaglycan, a coreceptor for inhibin A | Determines inhibin A-specific signaling in gonadotrope cells |
| ACVR2A | Encodes a type II receptor for activin/inhibin signaling | Mediates downstream signaling antagonized by inhibin A |
| ACVR2B | Encodes another type II receptor in the TGF-beta superfamily | Contributes to activin/inhibin receptor complex assembly |
| ACVR1B | Encodes a type I receptor in the activin signaling pathway | Transduces signals that inhibin A can antagonize |
| ACVR1C | Encodes a type I receptor family member | Part of the receptor network relevant to inhibin A biology |
| SMAD2 | Intracellular effector of TGF-beta/activin signaling | Readout of pathway activity modulated by inhibin A |
| SMAD3 | Intracellular effector of TGF-beta/activin signaling | Readout of pathway activity modulated by inhibin A |
| SMAD4 | Common mediator of TGF-beta superfamily signaling | Central node for inhibin A-related signaling |
| IGSF1 | Immunoglobulin superfamily member implicated in inhibin B receptor search | Context for understanding inhibin receptor specificity |
| FSHB | Encodes the beta subunit of follicle-stimulating hormone | Functional readout of inhibin A action in pituitary cells |
| GNRHR | Encodes the gonadotropin-releasing hormone receptor | Upstream regulator of gonadotrope function relevant to inhibin A |
| CGA | Encodes the common alpha subunit of glycoprotein hormones | Related to pituitary hormone biology |
| LHB | Encodes the beta subunit of luteinizing hormone | Related to gonadotrope function and endocrine feedback |
| CYP19A1 | Encodes aromatase, involved in estrogen synthesis | Links inhibin A biology to gonadal steroidogenesis |
How Is inhibin A complex Regulated?
Inhibin A complex formation and activity are regulated at multiple levels. Follistatin binds inhibin A to form a stable complex, which may affect its availability and clearance without blocking its ability to antagonize activin A. Betaglycan (TGFBR3) acts as a coreceptor that is required for inhibin A-specific signaling in pituitary gonadotrope cells, and its expression levels can influence responsiveness to inhibin A. The search for an inhibin B receptor has highlighted the complexity of receptor-coreceptor interactions in this family, with IGSF1 and betaglycan as key candidates. At the signaling level, inhibin A antagonizes activin A, which signals through type I and type II receptors and SMAD proteins, so the balance of ligands, receptors, and coreceptors determines the net output. Nanobodies against the inhibin alpha subunit provide additional tools to probe and potentially modulate these regulatory interactions.
inhibin A complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INHA | Tumor angiogenesis and metastasis | INHA knockout cancer cell line for angiogenesis assays |
| INHBA | Reproductive endocrine dysfunction | INHBA point-mutation cell model to alter subunit assembly |
| TGFBR3 | Pituitary gonadotrope signaling defects | TGFBR3 knockout gonadotrope cell line for inhibin A response |
| FST | Modulation of inhibin A bioavailability | FST overexpression cell model to study complex formation |
| ACVR2A | Activin/inhibin signaling imbalance | ACVR2A knockout cell line for SMAD readouts |
Inhibin A in tumor angiogenesis and metastasis
Inhibin has been identified as a novel paracrine factor for tumor angiogenesis and metastasis, indicating that the inhibin A complex can influence tumor progression beyond its classical endocrine roles. This finding suggests that inhibin A may promote the formation of new blood vessels and support metastatic spread, making it a potential target for anti-angiogenic or anti-metastatic strategies. Researchers studying cancer biology may therefore benefit from models that manipulate INHA and INHBA to dissect the contribution of the inhibin A complex to tumor phenotypes.
Reproductive and endocrine disorders
Inhibin A is a key regulator of FSH secretion, and its actions in the pituitary are mediated by betaglycan as a coreceptor. Disruption of inhibin A signaling could therefore contribute to reproductive and endocrine disorders characterized by altered gonadotropin levels. The neuroendocrinology of menopause involves changes in inhibin and activin signaling, highlighting the clinical relevance of this complex across the reproductive lifespan. In vitro studies have shown that inhibin A and activin A affect oocyte maturation, linking the complex to fertility and assisted reproduction.
TGF-beta superfamily signaling in disease
As a member of the TGF-beta superfamily, the inhibin A complex participates in signaling networks that are frequently dysregulated in disease. Structural studies of TGF-beta with betaglycan and signaling receptors have revealed mechanisms of complex assembly that are shared across the family, providing a framework for understanding how mutations or expression changes in inhibin A components might alter signaling. The continuing search for the inhibin B receptor underscores how much remains to be learned about receptor specificity in this family, with implications for endocrine and metabolic diseases.
From inhibin A complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of INHA abolish inhibin A complex formation? | INHA knockout cell line |
| Does a specific point mutation in INHBA alter heterodimer assembly? | INHBA point-mutation knock-in cell line |
| Can tagged inhibin A be tracked in secretion assays? | Tagged knock-in of INHA or INHBA |
| Does betaglycan mediate inhibin A-specific signaling? | TGFBR3 knockout or overexpression in gonadotrope cells |
| Does follistatin binding change inhibin A function? | FST overexpression or knockout cell model |
| Can inhibin A be detected with nanobodies? | Nanobody-based detection in inhibin A-expressing cells |
How to Study the inhibin A complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nanobody-based ELISA | Inhibin A protein levels | Detection in cell supernatants and tissues |
| Co-immunoprecipitation | Protein-protein interactions | Inhibin A-follistatin complex formation |
| Western blot | Subunit expression and processing | INHA and INHBA protein analysis |
| SMAD phosphorylation assay | Activin/inhibin signaling activity | Functional readout of inhibin A antagonism |
| FSHB reporter assay | Gonadotrope response | Inhibin A activity in pituitary cells |
| CRISPR knockout | Gene function loss | INHA, INHBA, TGFBR3 perturbation |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking inhibin A assembly and secretion |
| Phage display | Nanobody selection | Generating anti-inhibin alpha reagents |
Detection and quantification of inhibin A
Inhibin A can be detected and quantified using immunoassays and nanobody-based reagents. Nanobodies against the inhibin alpha subunit have been selected from a phage display library, providing sensitive and specific tools for detection. These reagents can be used in ELISA, Western blot, or imaging formats to measure inhibin A levels in cell culture supernatants and tissues.
Complex formation and interaction assays
Co-immunoprecipitation and pull-down assays can be used to study the interaction between inhibin A and follistatin, as well as the assembly of the alpha and beta-A subunits. These methods help determine whether mutations or expression changes affect complex stability. Surface plasmon resonance and related biophysical techniques can quantify binding affinities between inhibin A and its partners.
Signaling readouts
Because inhibin A antagonizes activin A signaling, downstream readouts such as SMAD2/3 phosphorylation and transcriptional reporters can be used to measure its functional impact. In pituitary gonadotrope cells, FSH beta (FSHB) expression and secretion serve as classic readouts of inhibin A action. These assays are essential for linking molecular changes in the inhibin A complex to cellular responses.
Genetic perturbation with CRISPR
CRISPR-Cas9 knockout, point mutation, and knock-in strategies enable precise manipulation of INHA, INHBA, TGFBR3, and FST to study the inhibin A complex. These models allow researchers to test causality and dissect structure-function relationships in a physiologically relevant context. Combining CRISPR models with the detection and signaling assays described above provides a comprehensive toolkit for inhibin A research.
How CRISPR Can Be Used to Study GO:0043512 inhibin A complex
Knockout
CRISPR knockout of INHA or INHBA eliminates the corresponding subunit, preventing formation of the inhibin A complex and enabling loss-of-function studies. Knockout of TGFBR3 removes the inhibin A coreceptor, allowing researchers to test its requirement for inhibin A-specific signaling in gonadotrope cells. These models are foundational for establishing causality in inhibin A biology.
Point Mutation
Point mutations can be introduced into INHA or INHBA to alter specific residues involved in subunit interaction, secretion, or receptor binding. Such models help dissect structure-function relationships without completely abolishing protein expression. They are particularly useful for studying the selectivity of inhibin A for betaglycan versus other coreceptors.
Knock-in
Knock-in of epitope tags or fluorescent proteins into INHA or INHBA allows real-time tracking of inhibin A assembly, secretion, and localization. Tagged knock-in models can also facilitate purification of the inhibin A complex for biochemical and structural studies. These approaches complement antibody-based detection methods such as nanobody reagents.
Overexpression
Overexpression of INHA and INHBA can drive production of the inhibin A complex in cell lines that normally express low levels, enabling gain-of-function experiments. Overexpression of FST can be used to study how follistatin modulates inhibin A bioavailability and function. These models are valuable for testing whether increased inhibin A signaling contributes to phenotypes such as tumor angiogenesis.
How EDITGENE Supports inhibin A complex Research
Researchers studying inhibin A complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise perturbation of INHA, INHBA, TGFBR3, FST, and related genes, coupled with functional assays to validate the effects on inhibin A biology.
Contact EDITGENE today to design your custom CRISPR model for inhibin A complex research.
Frequently Asked Questions About inhibin A complex
What is the inhibin A complex?
The inhibin A complex (GO:0043512) is a heterodimeric hormone composed of an inhibin alpha subunit and an inhibin beta-A subunit.
What genes are involved in the inhibin A complex?
The core genes are INHA (alpha subunit) and INHBA (beta-A subunit), with modulators such as FST and the coreceptor TGFBR3.
What is the function of inhibin A?
Inhibin A regulates FSH secretion and antagonizes activin A signaling, and it can act as a paracrine factor in tumor angiogenesis.
How does inhibin A differ from inhibin B?
Inhibin A uses betaglycan (TGFBR3) as a coreceptor in pituitary gonadotrope cells, whereas inhibin B does not.
What is the role of follistatin in inhibin A biology?
Follistatin forms a stable complex with inhibin A without interfering with its ability to antagonize activin A.
Is inhibin A involved in cancer?
Yes, inhibin has been identified as a paracrine factor for tumor angiogenesis and metastasis.
How can I study the inhibin A complex in the lab?
You can use CRISPR knockout, point mutation, knock-in, and overexpression models combined with nanobody-based detection and signaling assays.
What is the GO ID for inhibin A complex?
The GO ID is GO:0043512, and it belongs to the cellular_component ontology.
Does inhibin A affect oocyte maturation?
Inhibin A and activin A have been shown to affect in vitro maturation of bovine oocytes.
What tools are available to detect inhibin A?
Nanobodies against the inhibin alpha subunit have been developed for detection and functional studies.
Conclusion
The inhibin A complex (GO:0043512) is a heterodimeric TGF-beta superfamily hormone with essential roles in endocrine regulation, reproductive biology, and cancer. Its interactions with follistatin and the coreceptor betaglycan define its unique signaling properties and distinguish it from related ligands such as inhibin B. Continued research using CRISPR-based cell models, nanobody detection, and signaling assays will further clarify how this complex contributes to health and disease.
References
- 1. Kappes EC et al.. 2023. Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism.. Endocrinology 164(3) PMID: 36718082
- 2. Singh P et al.. 2018. Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.. Cancer Res 78(11):2978-2989 PMID: 29535220
- 3. Bernard DJ et al.. 2020. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.. Trends Endocrinol Metab 31(1):37-45 PMID: 31648935
- 4. Dasgupta A et al.. 2006. Neuroendocrinology of menopause.. Minerva Ginecol 58(1):25-33 PMID: 16498368
- 5. Ma J et al.. 2024. Screening and identification of nanobody against inhibin α-subunit from a Camelus bactrianus phage display library.. Heliyon 10(17):e36180 PMID: 39281437
- 6. Stock AE et al.. 1997. Effects of inhibin A and activin A during in vitro maturation of bovine oocytes in hormone- and serum-free medium.. Biol Reprod 56(6):1559-64 PMID: 9166710
- 7. Wieteska Ł et al.. 2025. Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling.. Nat Commun 16(1):1778 PMID: 40011426
- 8. Li Y et al.. 2018. Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice.. Endocrinology 159(12):4077-4091 PMID: 30364975
